Literature DB >> 19475334

The oxidative stress status in diabetes mellitus and diabetic nephropathy.

Hong-zhi Pan1, Lin Zhang, Mei-yi Guo, Hong Sui, Hui Li, Wei-hua Wu, Nai-qiang Qu, Mei-hua Liang, Dong Chang.   

Abstract

The aim of this study is to assess the oxidative stress status in diabetes mellitus (DM) and diabetic nephropathy. The study group comprised 40 control subjects, 40 type 2 DM patients without complications and 37 diabetic nephropathies. Compared with control subjects, superoxide dismutase, glutathione peroxidase, catalase, vitamin C were decreased (P < 0.01). There was a significant increase in serum malondialdehyde (MDA), conjugated diene (CD), advanced oxidation protein products (AOPP), protein carbonyl (PC) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in diabetes patients when compared with normal subjects (P < 0.01). Moreover, these indexes were much higher in diabetic nephropathy than that of diabetic patients without vascular complications (P < 0.05, P < 0.01). There was a significant correlation between the serum glucose levels and PC, 8-OHdG (P < 0.05, P < 0.01). There were highly significant positive correlation of CD and MDA, AOPP and PC (P < 0.01). Plasma AOPP levels had a significant correlation with PC levels (P < 0.01). Our findings suggested that diabetes patients have more severe oxidative stress than normal persons and higher oxidative stress in diabetic nephropathy than those in patients without complications. Oxidative stress may play an important intermediary role in the pathogenesis of diabetes complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475334     DOI: 10.1007/s00592-009-0128-1

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  49 in total

1.  Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography.

Authors:  Peifeng Dai; Junhua Wang; Lin Lin; Yanyan Zhang; Zhengping Wang
Journal:  Exp Ther Med       Date:  2015-06-22       Impact factor: 2.447

2.  Serum 25-hydroxyvitamin D level and diabetic nephropathy in patients with type 2 diabetes mellitus.

Authors:  Yan Peng; Liu-Juan Li
Journal:  Int Urol Nephrol       Date:  2015-04-24       Impact factor: 2.370

Review 3.  Mitochondrial allostatic load puts the 'gluc' back in glucocorticoids.

Authors:  Martin Picard; Robert-Paul Juster; Bruce S McEwen
Journal:  Nat Rev Endocrinol       Date:  2014-03-25       Impact factor: 43.330

Review 4.  Antioxidant role of zinc in diabetes mellitus.

Authors:  Kyria Jayanne Clímaco Cruz; Ana Raquel Soares de Oliveira; Dilina do Nascimento Marreiro
Journal:  World J Diabetes       Date:  2015-03-15

5.  Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.

Authors:  Su-Tze Chou; Shih-Ting Tseng
Journal:  Clin Exp Nephrol       Date:  2016-05-27       Impact factor: 2.801

6.  Dietary manganese and type 2 diabetes mellitus: two prospective cohort studies in China.

Authors:  Shanshan Du; Xiaoyan Wu; Tianshu Han; Wei Duan; Lei Liu; Jiayue Qi; Yucun Niu; Lixin Na; Changhao Sun
Journal:  Diabetologia       Date:  2018-07-03       Impact factor: 10.122

7.  Peripheral blood mitochondrial DNA copy number as a novel potential biomarker for diabetic nephropathy in type 2 diabetes patients.

Authors:  Ghada Al-Kafaji; Abdulah Aljadaan; Amer Kamal; Moiz Bakhiet
Journal:  Exp Ther Med       Date:  2018-06-15       Impact factor: 2.447

8.  Mannose-Binding Lectin and Diabetic Nephropathy in Type 1 Diabetes.

Authors:  Shi-Qi Zhao; Zhao Hu
Journal:  J Clin Lab Anal       Date:  2015-07-24       Impact factor: 2.352

Review 9.  Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

Authors:  D Allan Butterfield; Fabio Di Domenico; Eugenio Barone
Journal:  Biochim Biophys Acta       Date:  2014-06-17

10.  Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes.

Authors:  Siwei Zhang; Huali Xu; Xiaofeng Yu; Yi Wu; Dayun Sui
Journal:  Exp Ther Med       Date:  2017-05-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.